<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e> <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> is closely associated with clinical staging and has been proposed to correlate with clinical response in terms of subsequent <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> following primary resection </plain></SENT>
<SENT sid="1" pm="."><plain>Netrin-4 (NT-4) regulates angiogenic responses </plain></SENT>
<SENT sid="2" pm="."><plain>Therefore, we sought to examine the effects of NT-4 on the <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e> growth of <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells, liver and <z:e sem="disease" ids="C0153676" disease_type="Neoplastic Process" abbrv="">lung metastases</z:e> of <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells, and responses following <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e> resection </plain></SENT>
<SENT sid="3" pm="."><plain>We used 3 different mouse models of orthotopic <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e> and liver and <z:e sem="disease" ids="C0153676" disease_type="Neoplastic Process" abbrv="">lung metastases</z:e>, comparing 2 human <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells lines: <z:mp ids='MP_0002169'>wild-type</z:mp> (low expression of NT-4) and NT-4 (overexpression of NT-4) LS174 cells </plain></SENT>
<SENT sid="4" pm="."><plain>NT-4 overexpression inhibited the <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e> growth of colorectal LS174 xenografts in <z:mp ids='MP_0003815'>nude</z:mp> mice (144.3±12.9 vs. 62.4±4.5 mm3; p&lt;0.0001) as well as its related local and systemic recurrence (38 vs. 0%; p&lt;0.01) </plain></SENT>
<SENT sid="5" pm="."><plain>NT-4 overexpression also markedly decreased <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> progression in terms of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> number and volume of <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> in the NT-4 group of the orthotopic <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> model (25 vs. 90% and 4±1 vs. 709±190 mm3, p&lt;0.001 and p&lt;0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>Collectively, our findings indicate that NT-4 overexpression decreases colorectal lung <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> and its associated lymph node involvement </plain></SENT>
<SENT sid="7" pm="."><plain>NT-4 overexpression decreases <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> recurrence and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> after surgical resection, likely via an anti-angiogenic effect </plain></SENT>
<SENT sid="8" pm="."><plain>These observations suggest that NT-4 may hold therapeutic potential in the treatment of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> growth and major metastatic sites </plain></SENT>
</text></document>